Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling
US8506499B2 · kind B2 · utility
2Cited by
10References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 4, 2008 |
| Grant date | Aug 13, 2013 |
| Priority date | — |
| Expiry date | Sep 7, 2029 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/54
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Disclosed herein are methods of and systems for predicting recurrence of atrial fibrillation comprising protease and protease inhibitor profiling. The levels of matrix metalloproteinases (MMPs) and/or tissue inhibitor metalloproteinases (TIMPs) are analyzed to predict the recurrence of atrial fibrillation, and further to predict whether cardioversion will provide a successful therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.